Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C. Molecules. 2022 Sep;27(18):5904.

11 Sep 2022
0

Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study
Translational Proteomic Approach for Cholangiocarcinoma Biomarker Discovery, Validation, and Multiplex Assay Development: A Pilot Study. 

Watcharatanyatip K., Chutipongtanate S., Chokchaichamnankit D., Weeraphan C., Mingkwan K., Luevisadpibul V., Newburg D.S., Morrow A.L., Svasti J. and Srisomsap C. 

Molecules. 2022 Sep;27(18):5904.

Tags

Share this

Related Posts

Identifying important life stages for monitoring and assessing risks from exposures to environmental contaminants: Results of a World Health Organization review. Cohen Hubal, E. A., de Wet, T., Du Toit, L., Firestone, M. P., Ruchirawat, M., van Engelen, J., & Vickers, C. (2014). Regulatory Toxicology and Pharmacology, 69(1), 113-124.
Elevated O-GlcNAcylation of extracellular vesicle proteins derived from metastatic colorectal cancer cells. Chaiyawat P, Weeraphan C, Netsirisawan P, Chokchaichamnankit D, Srisomsap C, Svasti J, Champattanachai V*. Cancer Genom Proteom 2016;13(5):387-98.

Recent Posts